Compare PRAX & ESTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | ESTC |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 5.6B |
| IPO Year | 2020 | 2018 |
| Metric | PRAX | ESTC |
|---|---|---|
| Price | $289.43 | $55.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 27 |
| Target Price | ★ $572.13 | $94.08 |
| AVG Volume (30 Days) | 308.0K | ★ 2.3M |
| Earning Date | 05-01-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,483,296,000.00 |
| Revenue This Year | N/A | $19.19 |
| Revenue Next Year | $6,395.88 | $13.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $26.70 | $49.90 |
| 52 Week High | $354.87 | $103.79 |
| Indicator | PRAX | ESTC |
|---|---|---|
| Relative Strength Index (RSI) | 37.95 | 47.55 |
| Support Level | $266.93 | $49.90 |
| Resistance Level | $322.32 | $65.04 |
| Average True Range (ATR) | 16.36 | 2.65 |
| MACD | -4.02 | 0.77 |
| Stochastic Oscillator | 4.20 | 86.29 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.